HeartBeam Reports Third Quarter 2026 Results November 12th, 2026|Business Wire| SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam Reports Third Quarter 2026 Results Please leave this field empty Subscribe to Our Newsletter We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information. Please check your Inbox or Spam folder now to confirm your subscription. Like this post? Share it! FacebookXLinkedInEmail Related Posts Lineage Announces Acquisition of NeuroAirmid Therapeutics and Clinical Stage Program for the Treatment of Huntington’s Disease November 12th, 2026 | 0 Comments Evommune Reports Third Quarter 2026 Financial Results and Provides Business Highlights November 12th, 2026 | 0 Comments Enhanced Group Inc. Reports Third Quarter 2026 Results November 12th, 2026 | 0 Comments Enhanced Group Brings Athlete-Tested Personalized Protocol-Making to Consumers With Launch of Enhanced OS, Expanding Its Offering Beyond Individual Products November 12th, 2026 | 0 Comments NeuroPace Reports Third Quarter 2026 Financial Results and Provides Revised Full Year Guidance November 12th, 2026 | 0 Comments Obsidian Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates November 12th, 2026 | 0 Comments Once Upon a Farm Reports Third Quarter 2026 Financial Results November 12th, 2026 | 0 Comments Vir Biotechnology Announces Pricing of Public Offering of Common Stock November 12th, 2026 | 0 Comments Tech-Inno Health Launches Branded Ingredients Business, Highlighting Urolithin A, S-Equol and Mulberry Leaf Extract November 12th, 2026 | 0 Comments Sensus Healthcare Reports Third Quarter 2026 Financial Results and Business Highlights November 12th, 2026 | 0 Comments Lineage Cell Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update November 12th, 2026 | 0 Comments Vir Biotechnology Announces Proposed Public Offering November 12th, 2026 | 0 Comments